framycetin has been researched along with cytosine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jones, PA; Shen, JC; Zingg, JM | 1 |
Aminova, O; Childs-Disney, JL; Disney, MD; Paul, DJ | 1 |
Hamasaki, K; Ikezawa, Y; Inoue, R; Katou, T; Watanabe, K | 1 |
Duchardt-Ferner, E; Krepl, M; Kruse, H; Sponer, J; Vögele, J; Wöhnert, J | 1 |
4 other study(ies) available for framycetin and cytosine
Article | Year |
---|---|
Enzyme-mediated cytosine deamination by the bacterial methyltransferase M.MspI.
Topics: Adenosine; Bacterial Proteins; Cytosine; Deamination; Deoxyadenosines; DNA (Cytosine-5-)-Methyltransferases; DNA-Binding Proteins; Molecular Structure; Moraxella; Mutation; Neomycin; S-Adenosylhomocysteine; S-Adenosylmethionine | 1998 |
Two-dimensional combinatorial screening identifies specific 6'-acylated kanamycin A- and 6'-acylated neamine-RNA hairpin interactions.
Topics: Acylation; Adenine; Base Sequence; Combinatorial Chemistry Techniques; Cytosine; Drug Evaluation, Preclinical; Framycetin; Inverted Repeat Sequences; Kanamycin; Ligands; RNA; Substrate Specificity | 2008 |
Nucleobase modified neamines with a lysine as a linker, their inhibition specificity for TAR-Tat derived from HIV-1.
Topics: Adenine; Cytosine; Framycetin; Guanine; HIV Long Terminal Repeat; HIV-1; Lysine; Molecular Structure; Structure-Activity Relationship; tat Gene Products, Human Immunodeficiency Virus; Thymine | 2015 |
An intricate balance of hydrogen bonding, ion atmosphere and dynamics facilitates a seamless uracil to cytosine substitution in the U-turn of the neomycin-sensing riboswitch.
Topics: Base Pairing; Binding Sites; Cations; Cytosine; Hydrogen Bonding; Ions; Ligands; Magnesium; Molecular Dynamics Simulation; Mutation; Neomycin; Nuclear Magnetic Resonance, Biomolecular; Nucleic Acid Conformation; Potassium; Riboswitch; Uracil | 2018 |